Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Adamski J, Godman B, Ofierska-Sujkowska G, Osińska B, Herholz H, Wendykowska K, Laius O, Jan S, Sermet C, Zara C, Kalaba M, Gustafsson R, Garuolienè K, Haycox A, Garattini S, Gustafsson LL. Adamski J, et al. Among authors: garattini s. BMC Health Serv Res. 2010 Jun 7;10:153. doi: 10.1186/1472-6963-10-153. BMC Health Serv Res. 2010. PMID: 20529296 Free PMC article. Review.
Switching Among Biosimilars: A Review of Clinical Evidence.
Allocati E, Godman B, Gobbi M, Garattini S, Banzi R. Allocati E, et al. Among authors: garattini s. Front Pharmacol. 2022 Aug 24;13:917814. doi: 10.3389/fphar.2022.917814. eCollection 2022. Front Pharmacol. 2022. PMID: 36091837 Free PMC article.
The drug market in four European countries.
Garattini S. Garattini S. Pharmacoeconomics. 1998;14 Suppl 1:69-79. doi: 10.2165/00019053-199814001-00010. Pharmacoeconomics. 1998. PMID: 10186484
Anything new in EU pharmacovigilance?
Garattini S, Bertele' V. Garattini S, et al. Eur J Clin Pharmacol. 2011 Nov;67(11):1199-200. doi: 10.1007/s00228-011-1052-1. Epub 2011 May 4. Eur J Clin Pharmacol. 2011. PMID: 21541780 No abstract available.
Do we learn the right things from clinical trials?
Garattini S, Bertele' V. Garattini S, et al. Eur J Clin Pharmacol. 2008 Feb;64(2):115-25. doi: 10.1007/s00228-007-0411-4. Epub 2008 Jan 29. Eur J Clin Pharmacol. 2008. PMID: 18228013 Review. No abstract available.
Limits of add-on trials: antirheumatic drugs.
Ottolenghi L, Bertele' V, Garattini S. Ottolenghi L, et al. Among authors: garattini s. Eur J Clin Pharmacol. 2009 Jan;65(1):33-41. doi: 10.1007/s00228-008-0545-z. Epub 2008 Sep 3. Eur J Clin Pharmacol. 2009. PMID: 18762934 Review.
882 results